The Drugs Controller General of India (DCGI) has issued an advisory to keep a strict watch on the sale and distribution of falsified versions of two drugs, Defitelio and Adcetris, following alerts from the World Health Organisation (WHO). The WHO has identified multiple falsified versions of Adcetris in circulation, and a falsified version of Defitelio has also been detected.
